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Abstract
The feasibility of using solid-state MAS NMR for in situ structural characterization of the LR11
(sorLA) transmembrane domain in native Escherichia coli (E. coli) membranes is presented. LR11
interacts with the human amyloid precursor protein (APP), a central player in the pathology of
Alzheimer's disease. The background signals from E. coli lipids and membrane proteins had only
minor effects on LR11 TM resonances. Approximately 50% of the LR11 TM residues were
assigned by using 13C PARIS data. These assignments allow comparisons of the secondary
structure of LR11 TM in native membrane environments and in commonly used membrane
mimics (e.g. micelles). In situ spectroscopy bypasses several obstacles in the preparation of
membrane proteins for structural analysis, and offers an opportunity to investigate the
consequences of membrane heterogeneity, bilayer asymmetry, chemical gradients, and
macromolecular crowding on the protein structure.
Integral membrane proteins reside in a complex lipid environment. The complexity of
cellular membranes is reflected in their diverse lipid composition (>1,000 different lipid
species), lateral heterogeneity (e.g. lipid rafts, lipid microdomains), transbilayer asymmetry,
chemical and electrical gradients, dynamics, and shapes.1–5 Membranes are no longer
viewed as simple passive barriers that separate cells from their environments, but rather as
active participants in important biological processes such as intracellular signal transduction,
protein localization and protein trafficking.6–8 Biological membranes are crowded and
contain as much protein as they do lipid.9,10 The implications of this intramolecular
crowding are increasingly recognized.11–14 Although the unique lipid environment is a
major determinant of membrane protein conformation and function, this environment is
incompatible with the conventional methods of X-ray crystallography and solution NMR.
Consequently, our structural knowledge of membrane proteins lags far behind that of soluble
proteins, despite the fact that membrane proteins account for approximately 30% of all
proteins in the human genome, including biologically crucial molecules such as ion channels
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and G-protein coupled receptors. As of April 2011, there are only ~280 unique membrane
protein structures in the Protein Data Bank, mostly from prokaryotes.
The importance of membrane mimetic environments in supporting the native structure,
dynamics and function of membrane proteins has been highlighted recently.23–26 So far,
most structural analyses were carried out in detergent preparations and only a few in
synthetic lipid bilayers. Information about protein structure in biological environments is
scarce.15–18 Bacteriorhodopsin is the only protein that has been subjected to in situ detailed
NMR structural characterizations in native purple membranes,19–22 thanks to its natural
abundance. Recent developments in the condensed Single-Protein-Production (cSPP) system
have allowed the detection of membrane proteins without purification.27–29 Here, we
demonstrate the feasibility of characterizing the transmembrane domain (TM) of a human
protein, LR11/SorLA, in situ in E. coli membranes by using solid-state magic-angle
spinning (MAS) NMR.
LR11 is a recently identified type I transmembrane protein involved in the development of
Alzheimer's disease (AD). AD causes a gradual loss of memory and general cognitive
decline. It is the most common form of dementia in the elderly and currently affects more
than 5.4 million Americans (http://www.alz.org). The “amyloid hypothesis” suggests that
the accumulation of Aβ peptides, proteolytic products of amyloid precursor protein (APP), is
the primary cause of AD.30,31 APP is a type I transmembrane protein and is continuously
sorted through multiple subcellular organelles (e.g. trans-Golgi network, plasma membrane
and endosome). Its aberrant intracellular trafficking is linked to the development of AD.
LR11 has emerged as a critical regulator for APP transport and processing.32–36 LR11
interacts directly with APP, regulating its subcellular localization. Variants of LR11 are
associated with AD, and the expression of LR11 is dramatically decreased in the brains of
patients suffering from sporadic AD.32,37,38 The transmembrane domains of LR11s from
mammals are highly conserved and share >95% sequence identity, pointing to their potential
functional significance. Using a new MBP-fusion expression vector, we produced human
LR11 TM (residues 2132 to 2161, Figure 1a) in E. coli.39 The recombinant protein is
expressed in the membranes at a much higher level relative to the background of E. coli
membrane proteins, as shown in Figure 1b. We have developed a protocol to cleave MBP at
the native membrane surface and have obtained LR11 TM in E. coli membranes through
ultracentrifugation and buffer washes. The SDS-PAGE result for the prepared sample is also
shown in Figure 1b. LR11 TM consists of 70~80% of total labeled proteins.
To examine sample homogeneity, spectral sensitivity and resolution, and the interference of
background signals from E. coli proteins and lipids, 13C MAS NMR spectra were acquired
on a 13Cα,β-Alanine enriched LR11 TM in isolated membranes. The phospholipid
composition of E. coli from exponentially grown cultures is simple, mainly
phosphatidylethanolamine, phosphatidylglycerol and cardiolipin.40 Despite the fact that
lipids are not labeled in this preparation, their naturally abundant signals overwhelm the 1D
spectrum collected with a single 90°-pulse direct polarization (DP) experiment (Figure 2a,
top). The resonances at ~17 and 52 ppm are relatively sharp and likely come from the
flexible lipid headgroups and methyl carbons, while the resonance at ~31 ppm comes from
the lipid methylene groups. The narrow resonances are effectively suppressed in the 1H-13C
cross polarization (CP) experiment, while the resonances from more rigid regions are greatly
enhanced (Figure 2a, middle). The lipid 13C signals can be further suppressed in the double-
quantum filter (CP-DQF)41 experiment and thus resonances solely from 13Cα,β-Alanine
enriched proteins are detected (Figure 2a, bottom). These DP, CP and CPDQF spectra were
collected in ~45, 17 and 70 minutes, respectively, on a 600 MHz spectrometer, suggesting
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that the sensitivity is sufficient for multidimensional NMR experiments to improve spectral
resolution.
A 2D 13C-13C PARIS42 spectrum is shown in Figure 2b. The resonance line-width is ~1.0
ppm which is typical for non-crystalline samples and indicates good homogeneity of the
preparation. Two well-resolved and two partially overlapped cross peaks are observed in the
Ala Cα-Cβ chemical shift region as expected from the four Ala residues in the protein
sequence, consistent with the resonances arising from LR11 TM. One cross peak at 50.1 and
17.6 ppm is much weaker and has a slow PARIS buildup. This can be tentatively attributed
to the relatively flexible residue of Ala20 at the N-terminus of the TM domain.
To pursue resonance assignments and validate the secondary structure of the TM domain,
2D 13C PARIS spectra with various mixing times were collected on a uniformly 13C, 15N
enriched sample. The 13C-13C correlations are generated by through-spaced dipolar
couplings, thus at a short mixing time of 5 ms most of the cross peaks result from directly
bonded 13C sites (Figure 3a). Despite having lipids that are also 13C enriched, lipid
resonances do not interfere with the protein resonances because CP and dipolar-coupling
mediated magnetization transfer select against relatively flexible lipid resonances. The Ala
Cα-Cβ cross peak region, highlighted in the blue box, is identical to the above spectrum from
the 13Cα,β-Ala labeled sample. Based on their characteristic chemical shifts and spin
systems, the resonances of Ile, Ser, Val, Leu, and Gly are easily identified. The cross peak at
37.1 and 61.1 ppm was assigned to Cβ-Cα of Phe, with the aid of its connectivity to
resonances in the aromatic region (data not shown). The cross peak at 26.4 and 47.8 ppm
was attributed to Cγ-Cδ of Pro based on its unique chemical shifts and connectivity at a
longer mixing time (see below). Thus, all amino acid residue types of the LR 11 TM domain
were readily identified. The Cα and Cβ chemical shifts of Ile at 63.9 and 35.8 ppm, Leu at
56.2 and 40.0 ppm, Phe at 60.3 and 37.1 ppm, and Val at 64.3 and 29.7 ppm are indicative
of an α-helical backbone conformation.43 For helical membrane proteins, the overlapping
cross peaks of the same amino acid type are common. Resonances from some of the tag
residues are also detected (e.g. the cross peak at 53.6 and 40 ppm is likely from Asp and/or
Asn), but they generally show a signature of chemical exchange broadening due to the
relative flexibility of the tags.
Figures 3b and 3c show 2D 13C-13C PARIS spectra acquired with mixing times of 20 and
100 ms, respectively. The long mixing times permit magnetization transfers between 13C
spins, separated by multiple bonds or from different residues, and provide connectivity for
resonance assignment. Starting from the cross peak of Pro Cγ-Cδ, the cross peaks of Cβ-Cδ
and Cδ-Cα were identified in Figure 3b. Since there is only one Pro residue in the LR11 TM
sequence, the Cα and Cβ chemical shifts for residue Pro31 were obtained. Ile32 was
subsequently assigned based on its Cγ connectivity to the Cβ of Pro31 in Figure 3c. Six
PARIS cross peaks at 64.6, 60.4, 56.2, 40.7, 29.6, and 21.9 ppm were observed for Gly at
46.1 ppm with 100 ms mixing time, and they were assigned to Cα of Val, Phe, and Leu, and
Cβ of Leu, Val, and Ala, respectively, based on the amino acid type information in Figure
3a. Furthermore, a cross peak between Phe Cα at 61.1 ppm and Ala Cα at 48.4 ppm was
observed. These connectivities were mapped to the LGVGFA fragment in the TM sequence.
In addition, several cross peaks between Leu and Ile and between Phe and Leu were
identified, but could not be unambiguously assigned to specific sites without additional data.
Most of the unassigned peaks in Figure 3a come from residues of LBT and His tags, and a
few of them might be E. coli background signals. From 13C-13C PARIS data, we have
readily assigned 12 out of 23 residues of the LR11 TM and their chemical shifts are listed in
Table S1. All assigned residues show characteristic secondary shifts of an α-helix and are in
agreement with the secondary shifts44 of LR11 TM in DPC micelles (listed in Table S1)
except for residue Ala45. This residue is near the C-terminus of the predicted TM domain
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and resides in the membrane-solution interface region, where there are substantial
differences between bilayers and micelles and where structural discrepancy likely occurs.
Our studies have demonstrated the feasibility of in situ detection of the human LR11 TM
domain in native E. coli membranes. The spectral sensitivity and resolution are adequate for
a structural analysis of this small protein. Signals from lipids and membrane proteins of E.
coli are minimally interfered with the detection of LR11 TM resonances. By using 13C-13C
homonuclear correlation experiments, we have assigned ~50% of TM residues. Their
secondary chemical shifts are consistent with expected values for an α-helix conformation.
Most of the unassigned residues are Leu and Val because of their high abundance in the
sequence. We expect that the spectral resolution can be improved further by using
multidimensional heteronuclear correlation experiments and advanced enrichment
strategies.45–51
Although the composition of E. coli membranes differs from that of human cells, in situ
detection eliminates the use of detergents for extraction, purification and reconstitution of
recombinant membrane proteins. Moreover, our approach offers an opportunity to validate
and refine membrane protein structures in a native environment and investigate the
consequences of membrane heterogeneity, bilayer asymmetry, chemical gradients, and
macromolecular crowding on the protein structure, characteristics which cannot be
addressed in studies using detergent micelles and synthetic lipid bilayers.
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(a) Primary structure of the LBT-LR11TM-His6. The LR11 fragment is shown in bold,
corresponding to residues 2132 to 2161 of the full-length protein. The LBT (lanthanide
binding tag) is shown in italics. (b) SDS-PAGE results for the preparation of LR11 TM in
native E. coli membranes. Lanes: 1, protein marker; 2, isolated E. coli membrane fraction; 3,
thrombin cleavage of the sample in lane 2; 4, buffer washes of the sample in lane 3; 5,
prepared membrane fraction for NMR experiments.
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13C MAS spectra of 13Cα,β-Ala enriched LR11 TM in native E. coli membranes recorded at
305 K on a Bruker 600 MHz spectrometer using a home-built low-E 3.2 mm probe. The
spinning rate was 10 kHz. (a) 1D spectra recorded using DP, CP and CP-DQF polarization
schemes with 512, 512 and 2048 scans, 5, 2 and 2s recycle delays, respectively. (b) A
2D 13C-13C PARIS spectrum collected with 20 ms mixing time, 9.2 and 7.0 ms acquisition
time for direct and indirect dimensions, 1.5 s recycle delay and 512 scans per t1 point.
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2D 13C-13C PARIS spectra of 13C, 15N uniformly enriched LR11 TM in native E. coli
membranes recorded for resonance assignment with (a) 5 ms mixing time and 96 scans per
t1 point; (b) 20 ms mixing time and 112 scans per t1 point; (c) 100 ms mixing time and 128
scans per t1 point. The acquisition times for direct and indirect dimensions were 10.3 and
4.8 ms, and the recycle delay was 1.5 s.
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